Experiment: 2MXO

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
2	2D 1H-13C HSQC	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
3	3D HBHA(CO)NH	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
4	3D HNCO	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
5	3D HNCACB	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
6	3D 1H-13C NOESY aliphatic	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
7	3D 1H-13C NOESY aromatic	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
8	3D 1H-15N NOESY	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
9	3D HCCH-TOCSY	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298
10	3D HBHA(CO)NH	300 uM [U-99% 13C; U-99% 15N] GWHhn2b-1, 20 mM Sodium acetate-2, 5 % D2O-3	95% H2O/5% D2O	20	5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	Stereochemical property by Molprobity
Conformers Calculated Total Number	30
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
2	collection	TopSpin		Bruker Biospin
3	chemical shift assignment	CcpNmr Analysis	2.4	CCPN
4	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.